NCT06005987 Mobile App Logging for Diabetes in Pregnancy
| NCT ID | NCT06005987 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Carolyn Zahler-Miller |
| Condition | Gestational Diabetes Mellitus in Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-06-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Eligibility Criteria
Inclusion Criteria: * 18 years and older * Verified intrauterine pregnancy * At least 12 weeks gestation * Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus. Exclusion Criteria: * Patients with less than 4 weeks anticipated to be remaining in pregnancy * Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking * Type 1 diabetes mellitus * Non-English speaking patients
Contact & Investigator
Rebecca Keipper, MD
PRINCIPAL INVESTIGATOR
Augusta University
Frequently Asked Questions
Who can join the NCT06005987 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 100 Years, studying Gestational Diabetes Mellitus in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06005987 currently recruiting?
Yes, NCT06005987 is actively recruiting participants. Contact the research team at rkeipper@augusta.edu for enrollment information.
Where is the NCT06005987 trial being conducted?
This trial is being conducted at Augusta, United States.
Who is sponsoring the NCT06005987 clinical trial?
NCT06005987 is sponsored by Carolyn Zahler-Miller. The principal investigator is Rebecca Keipper, MD at Augusta University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.